Pesquisa de referências

Genetics and life insurance : a view Into the microscope of regulation

Portada
Registro MARC
Tag12Valor
LDR  00000cam a22000004i 4500
001  MAP20170033523
003  MAP
005  20171018171032.0
008  171018s2017 che 000|0eng
040  ‎$a‎MAP‎$b‎spa‎$d‎MAP
084  ‎$a‎341
1001 ‎$0‎MAPA20160015294‎$a‎Klein, Ronald
24510‎$a‎Genetics and life insurance : a view Into the microscope of regulation‎$c‎by Ronald Klein
260  ‎$a‎Geneva‎$b‎The Geneva Association‎$c‎2017
520  ‎$a‎The use of genetic information for life, disability, critical illness and long-term care insurance is likely to increase in relevance as testing becomes more widespread and better clinical data emerges. Existing regulations generally apply to employment and health insurance. A country having no genetic-specific regulation for life, disability, critical illness or long-term care insurance implies that the country considers genetic information to be included with other medical information. However, it could simply mean that the country has not yet found the time, need or support necessary to enact a specific regulation. In these countries, the fact that industry groups may have attempted to fill a regulatory void by issuing codes of conduct for their member companies implies that the industry would prefer its own codes rather than sometimes unpredictable broader regulation
650 4‎$0‎MAPA20080570590‎$a‎Seguro de vida
650 4‎$0‎MAPA20080547424‎$a‎Genética
65011‎$0‎MAPA20080584634‎$a‎Derecho de seguros
650 4‎$0‎MAPA20080587451‎$a‎Regulación general
7102 ‎$0‎MAPA20080478728‎$a‎Association Internationale pour l'Etude de l'Economie de l'Assurance
7102 ‎$0‎MAPA20080463984‎$a‎European Association for Law and Economics